跳至主要内容
临床试验/NCT03529149
NCT03529149Unknown4 期

TCD Monitoring Technology Guides the Precise Control of Blood Pressure After EVT

Xuanwu Hospital, Beijing1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2018年4月8日最近更新:
适应症
干预措施

试验速览

阶段
4 期
入组人数
90
试验地点
1
主要终点
early neurological deterioration

研究概览

简要总结

Investigators hypothesized that the precise regulation of blood pressure based on the changes of cerebral blood flow parameters under TCD monitoring can better improve the state of cerebral blood flow, reduce the risk of early neurological deterioration and improve the prognosis of the patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age or older;
  • accept EVT treatment within 6 hours of symptoms onset;
  • In selected patients with AIS within 6 to 16 hours of last known normal who have LVO in the anterior circulation and meet other DAWN or DEFUSE 3 eligibility criteria..
  • In selected patients with AIS within 6 to 24 hours of last known normal who have LVO in the anterior circulation and meet other DAWN eligibility criteria.

排除标准

  • Pre - onset mRS>2;
  • severe dementia;
  • threatening life diseases (such as malignant tumor, etc.);
  • non acute ischemic cerebrovascular disease patients undergoing selective intravascular treatment;
  • related sound window closure can not be monitoring with TCD.

研究组 & 干预措施

Guideline blood pressure control

Active Comparator

Control blood pressure according to guidelines

干预措施: Urapidil Hydrochloride Injection (Combination Product)

Accurate blood pressure control

Experimental

Implementing accurate blood pressure management under TCD monitoring

干预措施: Urapidil Hydrochloride Injection (Combination Product)

结局指标

主要结局

early neurological deterioration

时间窗: 72 hours

the incidence of 72 hours in National Institute of Health stroke scale increased more than 4 points or National Institute of Health stroke scale Ia score more than 1 points

次要结局

  • prognosis of nerve function(3 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验